Emerging Biopharma

dynamic arrows moving up

Biotech

US biotechs must adapt as global competition rises: Antares CEO

Antares CEO Adam Friedman said he’s had to shift his strategy amid high costs, regulatory uncertainty and the rise of ex-U.S. competition.

Gabrielle Masson Jun 17, 2025 8:15am

Astellas

Astellas offers lab space to help Japanese biotechs 'go global'

Jun 13, 2025 4:41am

finance numbers tape money

Novo Nordisk inks $812M Deep Apple deal to pursue obesity target

Jun 11, 2025 7:00am

handshake deal shake hand arrows ok yes

Juri inks $210M T-cell engager deal with China biotech

May 27, 2025 6:00am

Nominations now open for Fierce Biotech's 2025 Fierce 15

May 20, 2025 7:30am

A sleek metallic pen tip creates a trail of pink and purple glitter blending technology with artistic expression

Stylus outlines next-gen gene editing mission with $85M in hand

May 13, 2025 7:00am

More News

Former Inhibikase CEO launches new biotech for Parkinson's asset

May 12, 2025 12:44pm

Tango dances away from preclinical work to extend cash runway

May 12, 2025 8:37am

Versant unveils new autoimmune biotech with $100M fundraise

Apr 24, 2025 8:00am

Boehringer slots synthetic lethal program into oncology pipeline

Apr 23, 2025 7:45am

See more stories